Opinion | June 08, 2023
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Data support that antibiotic aztreonam-avibactam (ATM-AVI) is effective and well-tolerated in treating infections caused by Gram-negative bacteria, with a similar safety profile to aztreonam alone
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
Pheezee is designed to assess musculoskeletal and neuromuscular health.
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Subscribe To Our Newsletter & Stay Updated
